Calcium supplementation to prevent pre-eclampsia: protocol for an individual participant data meta-analysis, network meta-analysis and health economic evaluation

Introduction Low dietary calcium intake is a risk factor for pre-eclampsia, a major contributor to maternal and perinatal mortality and morbidity worldwide. Calcium supplementation can prevent pre-eclampsia in women with low dietary calcium. However, the optimal dose and timing of calcium supplementation are not known. We plan to undertake an individual participant data (IPD) meta-analysis of randomised trials to determine the effects of various calcium supplementation regimens in preventing pre-eclampsia and its complications and rank these by effectiveness. We also aim to evaluate the cost-effectiveness of calcium supplementation to prevent pre-eclampsia. Methods and analysis We will identify randomised trials on calcium supplementation before and during pregnancy by searching major electronic databases including Embase, CINAHL, MEDLINE, CENTRAL, PubMed, Scopus, AMED, LILACS, POPLINE, AIM, IMSEAR, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform, without language restrictions, from inception to February 2022. Primary researchers of the identified trials will be invited to join the International Calcium in Pregnancy Collaborative Network and share their IPD. We will check each study’s IPD for consistency with the original authors before standardising and harmonising the data. We will perform a series of one-stage and two-stage IPD random-effect meta-analyses to obtain the summary intervention effects on pre-eclampsia with 95% CIs and summary treatment–covariate interactions (maternal risk status, dietary intake, timing of intervention, daily dose of calcium prescribed and total intake of calcium). Heterogeneity will be summarised using tau2, I2 and 95% prediction intervals for effect in a new study. Sensitivity analysis to explore robustness of statistical and clinical assumptions will be carried out. Minor study effects (potential publication bias) will be investigated using funnel plots. A decision analytical model for use in low-income and middle-income countries will assess the cost-effectiveness of calcium supplementation to prevent pre-eclampsia. Ethics and dissemination No ethical approvals are required. We will store the data in a secure repository in an anonymised format. The results will be published in peer-reviewed journals. PROSPERO registration number CRD42021231276.

[1]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations , 2022, BMJ.

[2]  Ahmad Esmaillzadeh,et al.  Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial – EXPRESSION OF CONCERN , 2021, Public Health Nutrition.

[3]  Purchasing Power Parities and the Size of World Economies: Results from the 2017 International Comparison Program , 2020 .

[4]  S. Ziebland,et al.  A core outcome set for pre‐eclampsia research: an international consensus development study , 2020, BJOG : an international journal of obstetrics and gynaecology.

[5]  J. Staessen,et al.  Individual participant data meta‐analysis to examine interactions between treatment effect and participant‐level covariates: Statistical recommendations for conduct and planning , 2020, Statistics in medicine.

[6]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[7]  O. Norheim,et al.  A cost-effectiveness analysis of maternal and neonatal health interventions in Ethiopia , 2019, Health policy and planning.

[8]  L. Magee,et al.  Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial , 2019, The Lancet.

[9]  Ewout Steyerberg,et al.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects , 2018, British Medical Journal.

[10]  A. Ciapponi,et al.  Global inequities in dietary calcium intake during pregnancy: a systematic review and meta‐analysis , 2018, BJOG : an international journal of obstetrics and gynaecology.

[11]  James Lomas,et al.  Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data , 2018, BMJ Global Health.

[12]  Richard D Riley,et al.  Simulation-based power calculations for planning a two-stage individual participant data meta-analysis , 2018, BMC Medical Research Methodology.

[13]  Richard D Riley,et al.  Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples , 2017, British Medical Journal.

[14]  M. Azami,et al.  The effects of multi mineral-vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: An RCT , 2017, International journal of reproductive biomedicine.

[15]  A. Lefevre,et al.  Optimizing treatment for the prevention of pre-eclampsia/eclampsia in Nepal: is calcium supplementation during pregnancy cost-effective? , 2016, Cost Effectiveness and Resource Allocation.

[16]  Ian R White,et al.  Should multiple imputation be the method of choice for handling missing data in randomized trials? , 2016, Statistical methods in medical research.

[17]  Richard D Riley,et al.  One‐stage individual participant data meta‐analysis models: estimation of treatment‐covariate interactions must avoid ecological bias by separating out within‐trial and across‐trial information , 2016, Statistics in medicine.

[18]  Karl Claxton,et al.  Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  Richard D Riley,et al.  Meta‐analysis using individual participant data: one‐stage and two‐stage approaches, and why they may differ , 2016, Statistics in medicine.

[20]  L. Magee,et al.  Preventing deaths due to the hypertensive disorders of pregnancy , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[21]  Ahmad Esmaillzadeh,et al.  The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia. , 2016, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[22]  M. García-Molina,et al.  [Cost effectiveness of calcium supplement in reducing preeclampsia-related maternal mortality in Colombia]. , 2016, Revista de salud publica.

[23]  Ahmad Esmaillzadeh,et al.  Calcium-Vitamin D Co-supplementation Affects Metabolic Profiles, but not Pregnancy Outcomes, in Healthy Pregnant Women , 2016, International journal of preventive medicine.

[24]  R. Stoltzfus,et al.  Cluster-Randomized Non-Inferiority Trial to Compare Supplement Consumption and Adherence to Different Dosing Regimens for Antenatal Calcium and Iron-Folic Acid Supplementation to Prevent Preeclampsia and Anaemia: Rationale and Design of the Micronutrient Initiative Study , 2015, Journal of public health research.

[25]  Ahmad Esmaillzadeh,et al.  The Effect of Multi mineral-Vitamin D Supplementation on Pregnancy Outcomes in Pregnant Women at Risk for Pre-eclampsia , 2015, International journal of preventive medicine.

[26]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[27]  Nobhojit Roy,et al.  Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[28]  M. Torloni,et al.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2014, The Cochrane database of systematic reviews.

[29]  M. Torloni,et al.  Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[30]  Z. Asemi,et al.  Multivitamin Versus Multivitamin-mineral Supplementation and Pregnancy Outcomes: A Single-blind Randomized Clinical Trial , 2014, International journal of preventive medicine.

[31]  T. Cole,et al.  Randomized, placebo-controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth1234 , 2013, The American journal of clinical nutrition.

[32]  Catrin Tudur Smith,et al.  Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials , 2013, Statistics in medicine.

[33]  S Dias,et al.  Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.

[34]  J. Schwartz,et al.  Effect of Calcium Supplementation on Blood Lead Levels in Pregnancy: A Randomized Placebo-Controlled Trial , 2008, Environmental health perspectives.

[35]  G. Dildy,et al.  Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. , 2008, American journal of obstetrics and gynecology.

[36]  Robert E Black,et al.  What works? Interventions for maternal and child undernutrition and survival , 2008, The Lancet.

[37]  Eugene Demidenko,et al.  Sample size and optimal design for logistic regression with binary interaction , 2008, Statistics in medicine.

[38]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[39]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[40]  José Villar,et al.  World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. , 2006, American journal of obstetrics and gynecology.

[41]  Anna Donald,et al.  Dictionary of Health Economics , 1999, BMJ.

[42]  J. Cutler,et al.  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[43]  J. Villar,et al.  Calcium supplementation to prevent hypertensive disorders of pregnancy , 1991, The New England journal of medicine.

[44]  J. Repke,et al.  Pregnancy-induced hypertension and low birth weight: the role of calcium. , 1991, The American journal of clinical nutrition.

[45]  J. Repke,et al.  The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. , 1988, American journal of obstetrics and gynecology.

[46]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[47]  C. S. Pederson,et al.  SYMPOSIUM ON THE LACTIC ACID BACTERIA , 1952 .

[48]  Simon Grund,et al.  jomo: A Flexible Package for Two-level Joint Modelling Multiple Imputation , 2019, R J..

[49]  H. Scheepers,et al.  Should women be advised to use calcium supplements during pregnancy? A decision analysis , 2018, Maternal & child nutrition.

[50]  A. Culyer.  The Dictionary of Health Economics, Second Edition , 2010 .

[51]  G. ter Riet,et al.  Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.

[52]  Z. Mogyorósy,et al.  The main methodological issues in costing health care services: A literature review , 2005 .

[53]  B. Momcilovic.  Macroeconomics and health: Investing in health for economic development - report of the Commission on Macroeconomics and Health, WHO, Geneva 2001 (ISBN 92 4 154550 X) , 2002 .